Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 37 | 239 | 254 | 185 |
| Gross Profit | N/A | 37 | 239 | 254 | 185 |
| Operating Expenses | 27,378 | 20,503 | 24,183 | 25,240 | 15,611 |
| Operating Income | -27,378 | -20,466 | -23,944 | -24,986 | -15,426 |
| Interest Expense | 135 | 104 | 0 | 0 | 0 |
| Other Income | 32 | 124 | -108 | 190 | -253 |
| Pre-tax Income | -27,481 | -20,446 | -24,052 | -24,796 | -15,679 |
| Income Tax | 157 | 134 | 206 | 109 | 68 |
| Net Income Continuous | -27,638 | -20,580 | -24,258 | -24,905 | -15,747 |
| Net Income | $-27,638 | $-20,580 | $-24,258 | $-24,905 | $-15,747 |
| EPS Basic Total Ops | -28.94 | -21.59 | 847.53 | -26.54 | -33.28 |
| EPS Basic Continuous Ops | -28.90 | -21.59 | 847.58 | -26.60 | -33.32 |
| EPS Diluted Total Ops | -28.94 | -21.59 | 847.53 | -26.54 | -33.28 |
| EPS Diluted Continuous Ops | -28.90 | -21.59 | 847.58 | -26.60 | -33.32 |
| EBITDA(a) | $-27,267 | $-20,333 | $-23,721 | $-24,915 | $-15,255 |